{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:12:21Z","timestamp":1792807941865,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,8]],"date-time":"2027-04-08T00:00:00Z","timestamp":1807142400000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["P20GM130423"],"award-info":[{"award-number":["P20GM130423"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01 HL168126"],"award-info":[{"award-number":["R01 HL168126"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003284","name":"Pulmonary Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003284","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.chest.2025.11.033","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:04:17Z","timestamp":1764979457000},"page":"1018-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Subclinical Interstitial Lung Disease in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"169","author":[{"given":"Andrew L.","family":"Ormsby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kristen","family":"Demoruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-8365","authenticated-orcid":false,"given":"Joyce S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.chest.2025.11.033_bib2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/acr.24856","article-title":"Incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a population-based cohort","volume":"74","author":"Samhouri","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.chest.2025.11.033_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201108-1420PP","article-title":"Subclinical interstitial lung disease: why you should care","volume":"185","author":"Doyle","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2025.11.033_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.chest.2025.11.033_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.chest.2025.11.033_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"135","key":"10.1016\/j.chest.2025.11.033_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.202109-2087LE","article-title":"Prospective identification of subclinical interstitial lung disease in a rheumatoid arthritis cohort is associated with the MUC5B promoter variant","volume":"205","author":"Matson","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5152\/TurkThoracJ.2022.21263","article-title":"Screening for subclinical interstitial lung disease in rheumatoid arthritis patients: functional and radiological methods","volume":"23","author":"Abdelwahab","year":"2022","journal-title":"Turk Thorac J"},{"issue":"2 pt 1","key":"10.1016\/j.chest.2025.11.033_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2025.11.033_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","article-title":"Pulmonary involvement in early rheumatoid arthritis patients","volume":"30","author":"Habib","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.chest.2025.11.033_bib12","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.chest.2025.11.033_bib13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2025.11.033_bib14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.chest.2025.11.033_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103501","article-title":"Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?","volume":"23","author":"Akiyama","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurjrheum.2019.19044","article-title":"Interstitial lung abnormalities in patients with early rheumatoid arthritis: a pilot study evaluating prevalence and progression","volume":"6","author":"Dong","year":"2019","journal-title":"Eur J Rheumatol"},{"issue":"2","key":"10.1016\/j.chest.2025.11.033_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2025.11.033_bib18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.chest.2025.11.033_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ard.2004.034777","article-title":"Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s","volume":"64","author":"Goodson","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.chest.2025.11.033_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.chest.2025.11.033_bib21","first-page":"445","article-title":"Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden","volume":"24","author":"Wallberg-Jonsson","year":"1997","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.chest.2025.11.033_bib22","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/thoraxjnl-2016-208932","article-title":"Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis","volume":"71","author":"Bernstein","year":"2016","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.chest.2025.11.033_bib23","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/rheumatology\/kead027","article-title":"Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease","volume":"62","author":"Chang","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.chest.2025.11.033_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72768-z","article-title":"A prospective study of lung disease in a cohort of early rheumatoid arthritis patients","volume":"10","author":"Robles-Perez","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.chest.2025.11.033_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/resp.14645","article-title":"Early versus late onset interstitial lung disease in rheumatoid arthritis: an observational study of risk factors and mortality in Ontario, Canada","volume":"29","author":"Fidler","year":"2024","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.chest.2025.11.033_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.chest.2025.11.033_bib27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinbiochem.2008.06.014","article-title":"Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis","volume":"41","author":"Inui","year":"2008","journal-title":"Clin Biochem"},{"issue":"9","key":"10.1016\/j.chest.2025.11.033_bib28","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.chest.2025.11.033_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/03009749509099296","article-title":"Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis","volume":"24","author":"Luukkainen","year":"1995","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.chest.2025.11.033_bib30","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"23","key":"10.1016\/j.chest.2025.11.033_bib31","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2025.11.033_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.chest.2025.11.033_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.42812","article-title":"Plasma matrix metalloproteinase concentrations and risk of interstitial lung disease in a prospective rheumatoid arthritis cohort","volume":"76","author":"Luedders","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.chest.2025.11.033_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1056121","article-title":"Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis","volume":"9","author":"Pulito-Cueto","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152397","article-title":"Plasma Wnt7b protein in rheumatoid arthritis: detection of interstitial lung disease","volume":"228","author":"Rabie","year":"2023","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.chest.2025.11.033_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/thorax-2021-217822","article-title":"Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis","volume":"77","author":"Wu","year":"2022","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.chest.2025.11.033_bib37","first-page":"74","article-title":"Screening criteria for interstitial lung disease associated to rheumatoid arthritis: expert proposal based on Delphi methodology","volume":"19","author":"Narvaez","year":"2023","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.reuma.2019.05.007","article-title":"Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis","volume":"17","author":"Paulin","year":"2021","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.chest.2025.11.033_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823669","article-title":"Development of a risk nomogram model for identifying interstitial lung disease in patients with rheumatoid arthritis","volume":"13","author":"Xue","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.chest.2025.11.033_bib40","article-title":"Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management","volume":"9","author":"Yoo","year":"2022","journal-title":"Eur J Radiol Open"},{"issue":"11","key":"10.1016\/j.chest.2025.11.033_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm14113701","article-title":"A proposal for a new lung ultrasound score in rheumatoid arthritis: the reliability of lung ultrasound for rheumatoid arthritis-associated interstitial lung disease diagnosis","volume":"14","author":"Vicente-Rabaneda","year":"2025","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.chest.2025.11.033_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/acr.25348","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.chest.2025.11.033_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00337-2020","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","volume":"57","author":"Juge","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2025.11.033_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250339","article-title":"A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients","volume":"16","author":"Kur-Zalewska","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2025.11.033_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221135314","article-title":"Protective effect of methotrexate on lung function and mortality in rheumatoid arthritis-related interstitial lung disease: a retrospective cohort study","volume":"16","author":"Kim","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"12","key":"10.1016\/j.chest.2025.11.033_bib47","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/art.42640","article-title":"Identification, monitoring, and management of rheumatoid arthritis-associated interstitial lung disease","volume":"75","author":"Koduri","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.chest.2025.11.033_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reuma.2023.05.001","article-title":"CXCL10 as a biomarker of interstitial lung disease in patients with rheumatoid arthritis","volume":"20","author":"Makarem","year":"2024","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"1","key":"10.1016\/j.chest.2025.11.033_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.chest.2025.11.033_bib50","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/rheumatology\/kead535","article-title":"Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis","volume":"63","author":"Poole","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"1-2","key":"10.1016\/j.chest.2025.11.033_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imbio.2004.04.005","article-title":"The role of matrix metalloproteinase 7 in innate immunity","volume":"209","author":"Burke","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.chest.2025.11.033_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104883","article-title":"High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies","volume":"98","author":"Al-Adwi","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.chest.2025.11.033_bib53","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.4049\/jimmunol.164.11.5866","article-title":"Localization of lung surfactant protein D on mucosal surfaces in human tissues","volume":"164","author":"Madsen","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.chest.2025.11.033_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229997","article-title":"Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.chest.2025.11.033_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-9255-8-22","article-title":"Role of IL-33 in inflammation and disease","volume":"8","author":"Miller","year":"2011","journal-title":"J Inflamm (Lond)"},{"issue":"6","key":"10.1016\/j.chest.2025.11.033_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00192-2024","article-title":"Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease","volume":"10","author":"Ngo","year":"2024","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.chest.2025.11.033_bib57","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/rheumatology\/keae697","article-title":"Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis","volume":"64","author":"Wilson","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.chest.2025.11.033_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211022506","article-title":"Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis","volume":"13","author":"Furukawa","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225058155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225058155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:39:20Z","timestamp":1775641160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369225058155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0012369225058155"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2025.11.033","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical Interstitial Lung Disease in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}